|
|
|
|
Preface |
vii |
1 |
The Patient-Doctor Relationship |
1 |
2 |
Human Development Throughout the Life Cycle |
12 |
2.1 |
Normality |
12 |
2.2 |
Embryo, Fetus, Infant and Child |
18 |
2.3 |
Adolescence |
36 |
2.4 |
Adulthood |
45 |
2.5 |
Late Adulthood (Old Age) |
53 |
2.6 |
Death, Dying and Bereavement |
61 |
3 |
The Brain and Behavior |
70 |
3.1 |
Functional and Behavioral Neuroanatomy |
70 |
3.2 |
Neurophysiology and Neurochemistry |
94 |
3.3 |
Neuroimaging |
110 |
3.4 |
Electrophysiology |
117 |
3.5 |
Psychoneuroendocrinology, Psychoneuroimmunology
and Chronobiology |
121 |
3.6 |
Neurogenetics |
128 |
4 |
Contributions of the Psychosocial Sciences |
133 |
4.1 |
Jean Piaget |
133 |
4.2 |
Attachment Theory |
137 |
4.3 |
Learning Theory |
141 |
4.4 |
Aggression |
149 |
4.5 |
Sociobiology and Ethology |
157 |
4.6 |
Anthropology and Cross-Cultural Psychiatry |
165 |
4.7 |
Epidemiology and Biostatistics |
169 |
5 |
Clinical Neuropsychological Testing |
178 |
5.1 |
Clinical Neuropsychological Testing of
Intelligence and Personality |
178 |
5.2 |
Clinical Neuropsychological Assessment of Adults |
184 |
6 |
Theories of Personality and Psychopathology |
190 |
6.1 |
Sigmund Freud: Founder of Classic Psychoanalysis |
190 |
6.2 |
Erik Erikson |
207 |
6.3 |
Schools Derived from Psychoanalysis and Psychology |
214 |
7 |
Clinical Examination of the Psychiatric Patient |
227 |
7.1 |
Psychiatric History and Mental Status Examination |
227 |
7.2 |
Interviewing Techniques with Special Patient
Populations |
243 |
7.3 |
Physical Examination of the Psychiatric Patient |
248 |
7.4 |
Laboratory Tests in Psychiatry |
255 |
7.5 |
Medical Record and Medical Error |
267 |
8 |
Signs and Symptoms in Psychiatry |
272 |
9 |
Classification in Psychiatry and Psychiatric
Rating Scales |
284 |
9.1 |
Classification in Psychiatry |
284 |
9.2 |
Psychiatric Rating Scales |
309 |
10 |
Delirium, Dementia and Amnestic
and Other Cognitive Disorders |
319 |
10.1 |
Overview |
319 |
10.2 |
Delirium |
322 |
10.3 |
Dementia |
329 |
10.4 |
Amnestic Disorders |
344 |
10.5 |
Mental Disorders Due to a General Medical
Condition |
350 |
11 |
Neuropsychiatric Aspects of HIV Infection and
AIDS |
373 |
12 |
Substance-Related Disorders |
381 |
12.1 |
Introduction and Overview |
381 |
12.2 |
Alcohol-Related Disorders |
390 |
12.3 |
Amphetamine (or Amphetamine-like)-Related
Disorders |
407 |
12.4 |
Caffeine-Related Disorders |
412 |
12.5 |
Cannabis-Related Disorders |
417 |
12.6 |
Cocaine-Related Disorders |
421 |
12.7 |
Hallucinogen-Related Disorders |
428 |
12.8 |
Inhalant-Related Disorders |
435 |
12.9 |
Nicotine-Related Disorders |
438 |
12.10 |
Opioid-Related Disorders |
443 |
12.11 |
Phencyclidine (or Phencyclidine-like)-Related
Disorders |
450 |
12.12 |
Sedative-, Hypnotic-, or Anxiolytic
Related Disorders |
454 |
12.13 |
Anabolic-Androgenic Steroid Abuse |
460 |
12.14 |
Other Substance-Related Disorders |
464 |
13 |
Schizophrenia |
467 |
14 |
Other Psychotic Disorders |
498 |
14.1 |
Schizophreniform Disorder |
498 |
14.2 |
Schizoaffective Disorder |
501 |
14.3 |
Delusional Disorder and Shared Psychotic Disorder |
504 |
14.4 |
Brief Psychotic Disorder, Psychotic Disorder not
Otherwise Specified and Secondary Psychotic Disorders |
514 |
14.5 |
Culture-Bound Syndromes |
521 |
15 |
Mood Disorders |
527 |
15.1 |
Depression and Bipolar Disorder |
527 |
15.2 |
Dysthymia and Cyclothymia |
562 |
15.3 |
Other Mood Disorders |
568 |
16 |
Anxiety Disorders |
579 |
16.1 |
Overview |
579 |
16.2 |
Panic Disorder and Agoraphobia |
587 |
16.3 |
Specific Phobia and Social Phobia |
597 |
16.4 |
Obsessive-Compulsive Disorder |
604 |
16.5 |
Posttraumatic Stress Disorder and Acute Stress
Disorder |
612 |
16.6 |
Generalized Anxiety Disorder |
622 |
16.7 |
Other Anxiety Disorders |
627 |
17 |
Somatoform Disorders |
634 |
18 |
Chronic Fatigue Syndrome |
652 |
19 |
Factitious Disorders |
658 |
20 |
Dissociative Disorders |
665 |
21 |
Human Sexuality |
680 |
21.1 |
Normal Sexuality |
680 |
21.2 |
Abnormal Sexuality and Sexual Dysfunctions |
689 |
21.3 |
Paraphilias and Sexual Disorder not
Otherwise Specified |
705 |
22 |
Gender Identity Disorders |
718 |
23 |
Eating Disorders |
727 |
23.1 |
Anorexia Nervosa |
727 |
23.2 |
Bulimia Nervosa and Eating Disorder not Otherwise
Specified |
735 |
23.3 |
Obesity |
739 |
24 |
Normal Sleep and Sleep Disorders |
749 |
24.1 |
Normal Sleep |
749 |
24.2 |
Sleep Disorders |
753 |
25 |
Impulse-Control Disorders not Elsewhere Classified |
773 |
26 |
Adjustment Disorders |
786 |
27 |
Personality Disorders |
791 |
28 |
Psychosomatic Medicine |
813 |
28.1 |
Psychological Factors Affecting Physical
Conditions |
813 |
28.2 |
Consultation-Liaison Psychiatry |
828 |
29 |
Complementary and Alternative Medicine in
Psychiatry |
839 |
30 |
Psychiatry and Reproductive Medicine |
857 |
31 |
Relational Problems |
870 |
32 |
Problems Related to Abuse or Neglect |
874 |
33 |
Additional Conditions that may be a Focus of
Clinical Attention |
887 |
34 |
Emergency Psychiatric Medicine |
897 |
34.1 |
Suicide |
897 |
34.2 |
Psychiatric Emergencies in Adults |
907 |
34.3 |
Psychiatric Emergencies in Children |
918 |
35 |
Psychotherapies |
924 |
35.1 |
Psychoanalysis and Psychoanalytic Psychotherapy |
924 |
35.2 |
Brief Psychodynamic Psychotherapy |
931 |
35.3 |
Group Psychotherapy, Combined Individual and Group
Psychotherapy and Psychodrama |
934 |
35.4 |
Family Therapy and Couples Therapy |
940 |
35.5 |
Dialectical Behavior Therapy |
944 |
35.6 |
Genetic Counseling |
946 |
35.7 |
Biofeedback |
949 |
35.8 |
Behavior Therapy |
953 |
35.9 |
Cognitive Therapy |
958 |
35.10 |
Hypnosis |
961 |
35.11 |
Interpersonal Therapy |
964 |
35.12 |
Psychiatric Rehabilitation |
968 |
35.13 |
Combined Psychotherapy and Pharmacology |
971 |
36 |
Biological Therapies |
976 |
36.1 |
General Principles of Psychopharmacology |
976 |
36.2 |
Medication-Induced Movement Disorders |
992 |
36.3 |
α2-Adrenergic Receptor Agonists: Clonidine
and Guanfacine |
997 |
36.4 |
β-Adrenergic Receptor Antagonists |
1000 |
36.5 |
Anticholinergics and Amantadine |
1004 |
36.6 |
Anticonvulsants: Gabapentin,
Pregabalin,
Tiagabine,
Levetiracetam,
Topiramate
and Zonisamide |
1007 |
36.7 |
Antihistamines |
1011 |
36.8 |
Barbiturates and Similarly Acting Drugs |
1014 |
36.9 |
Benzodiazepines and Drugs Acting on
Benzodiazepine Receptors |
1018 |
36.10 |
Bupropion |
1023 |
36.11 |
Buspirone |
1026 |
36.12 |
Calcium Channel Inhibitors |
1027 |
36.13 |
Carbamazepine and Oxcarbazepine |
1029 |
36.14 |
Cholinesterase Inhibitors and Memantine |
1033 |
36.15 |
Dantrolene |
1037 |
36.16 |
Disulfiram and Acamprosate |
1038 |
36.17 |
Dopamine Receptor Agonists and Precursors: Apomorphine,
Bromocriptine,
Levodopa,
Pergolide,
Pramipexole
and Ropinirole |
1040 |
36.18 |
Dopamine Receptor Antagonists: Typical Antipsychotics |
1043 |
36.19 |
Lamotrigine |
1054 |
36.20 |
Lithium |
1056 |
36.21 |
Melatonin Agonists: Ramelteon
and Melatonin |
1063 |
36.22 |
Mirtazapine |
1064 |
36.23 |
Monoamine Oxidase Inhibitors |
1066 |
36.24 |
Nefazodone |
1070 |
36.25 |
Opioid Receptor Agonists: Methadone, Buprenorphine
and Levomethadyl |
1072 |
36.26 |
Opioid Receptor Antagonists: Naltrexone,
Nalmefene
and Naloxone |
1075 |
36.27 |
Phosphodiesterase-5 Inhibitors |
1078 |
36.28 |
Selective Serotonin-Norepinephrine
Reuptake Inhibitors |
1080 |
36.29 |
Selective Serotonin Reuptake Inhibitors |
1083 |
36.30 |
Serotonin-Dopamine Antagonists: Atypical Antipsychotics |
1091 |
36.31 |
Sympathomimetics and Related Drugs |
1098 |
36.32 |
Thyroid Hormones |
1103 |
36.33 |
Trazodone |
1105 |
36.34 |
Tricyclics and Tetracyclics |
1106 |
36.35 |
Valproate |
1113 |
36.36 |
Yohimbine |
1116 |
36.37 |
Brain Stimulation Methods |
1117 |
36.37.1 |
Electroconvulsive Therapy |
1117 |
36.37.2 |
Other Brain Stimulation Methods |
1124 |
37 |
Child Psychiatry: Assessment, Examination and
Psychological Testing |
1127 |
38 |
Mental Retardation |
1138 |
39 |
Learning Disorders |
1158 |
40 |
Motor Skills Disorder: Developmental Coordination
Disorder |
1170 |
41 |
Communication Disorders |
1175 |
42 |
Pervasive Developmental Disorders |
1191 |
43 |
Attention-Deficit Disorders |
1206 |
44 |
Disruptive Behavior Disorders |
1218 |
45 |
Feeding and Eating Disorders of Infancy or Early
Childhood |
1228 |
46 |
Tic Disorders |
1235 |
47 |
Elimination Disorders |
1244 |
48 |
Other Disorders of Infancy, Childhood and
Adolescence |
1250 |
48.1 |
Reactive Attachment Disorder of Infancy or Early
Childhood |
1250 |
48.2 |
Stereotypic Movement Disorder and Disorder of
Infancy, Childhood, or Adolescence not Otherwise Specified |
1254 |
49 |
Mood Disorders and Suicide in Children and
Adolescents |
1258 |
49.1 |
Depressive Disorders and Suicide in Children and
Adolescents |
1258 |
49.2 |
Early-Onset Bipolar Disorders |
1266 |
50 |
Anxiety Disorders of Infancy, Childhood and
Adolescence |
1270 |
50.1 |
Obsessive-Compulsive Disorder of Infancy, Childhood
and Adolescence |
1270 |
50.2 |
Posttraumatic Stress Disorder of Infancy,
Childhood and Adolescence |
1274 |
50.3 |
Separation Anxiety Disorder, Generalized Anxiety
Disorder and Social Phobia |
1277 |
50.4 |
Selective Mutism |
1286 |
51 |
Early-Onset Schizophrenia |
1289 |
52 |
Adolescent Substance Abuse |
1294 |
53 |
Child Psychiatry: Additional Conditions that may
be a Focus of Clinical Attention |
1299 |
54 |
Psychiatric Treatmient
of Children and Adolescents |
1306 |
54.1 |
Individual Psychotherapy |
1306 |
54.2 |
Group Psychotherapy |
1312 |
54.3 |
Residential, Day and Hospital Treatment |
1315 |
54.4 |
Biological Therapies |
1318 |
54.5 |
Psychiatric Treatment of Adolescents |
1326 |
55 |
Child Psychiatry: Special Areas of Interest |
1330 |
55.1 |
Forensic Issues in Child Psychiatry |
1330 |
55.2 |
Adoption and Foster Care |
1333 |
55.3 |
Child Maltreatment and Abuse |
1337 |
55.4 |
Impact of Terrorism on Children |
1344 |
56 |
Geriatric Psychiatry |
1348 |
57 |
End of Life Care and Palliative Medicine |
1359 |
57.1 |
Palliative Medicine and Pain Management |
1359 |
57.2 |
Euthanasia and Physician-Assisted Suicide |
1367 |
58 |
Clinical-Legal Issues in Psychiatry |
1371 |
59 |
Ethics in Psychiatry |
1383 |
|
Index |
1393 |
|
|
|